Vemurafenib-induced toxic epidermal necrolysis: possible cross-reactivity with other sulfonamide compounds-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Vemurafenib-induced toxic epidermal necrolysis: possible cross-reactivity with other sulfonamide compounds

Published:2015-12-30 Issue:3 Volume:174 Page:621-624
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Bellón T.¹,Lerma V.²,González-Valle O.³,González Herrada C.³,de Abajo F.J.²⁴

Affiliation:

1. Institute for Health Research; University Hospital La Paz-IdiPAZ; P° Castellana 261 28046 Madrid Spain

2. Clinical Pharmacology Unit; Principe de Asturias University Hospital; Madrid Spain

3. Department of Dermatology; University Hospital of Getafe; Madrid Spain

4. Department of Biomedical Sciences (Pharmacology); University of Alcalá; Madrid Spain

Funder

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjd.14201/fullpdf

Reference14 articles.

1. Improved survival with vemurafenib in melanoma with BRAF V600E mutation;Chapman;N Engl J Med,2011

2. Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma;Long;N Engl JMed,2014

3. Cutaneous adverse events associated with vemurafenib in patients with metastatic melanoma: practical advice on diagnosis, prevention and management of the main treatment-related skin toxicities;Sinha;Br J Dermatol,2012

4. Successful desensitization in a case of Stevens-Johnson syndrome due to vemurafenib;Minor;Melanoma Res,2012

5. Vemurafenib-induced toxic epidermal necrolysis;Wantz;Ann Dermatol Venereol,2014

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CACA guidelines for holistic integrative management of anticancer treatment - induced cutaneous adverse events;Holistic Integrative Oncology;2024-06-28

2. Arzneimittelexantheme unter Immun- und zielgerichteter onkologischer Therapie;Die Dermatologie;2024-05-21

3. Emerging Insights into Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Induced by Immune Checkpoint Inhibitor and Tumor-Targeted Therapy;Journal of Inflammation Research;2024-04

4. Cutaneous adverse reactions resulting from targeted cancer therapies: histopathologic and clinical findings;Human Pathology;2023-10

5. Evaluation of Delayed-Type Hypersensitivity to Antineoplastic Drugs—An Overview;Cancers;2023-02-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3